Literature DB >> 3871109

Purification and physicochemical characterization of murine T cell replacing factor (TRF).

K Takatsu, N Harada, Y Hara, Y Takahama, G Yamada, K Dobashi, T Hamaoka.   

Abstract

Murine T cell replacing factor (TRF) was purified from a cellfree supernatant of a T cell hybridoma (B151K12) that constitutively produces TRF. Two assay systems for TRF activity were employed: 1) induction of anti-DNP IgG PFC responses in cultures of splenic B cells from DNP-KLH-primed BALB/c mice, and 2) induction of IgM PFC in chronic B cell leukemic cells (BCL1). The purification scheme consisted of ammonium sulfate precipitation, DEAE-cellulose chromatography, Blue-Sepharose chromatography, hydroxylapatite chromatography, gel permeation with fast protein liquid chromatography (FPLC), and disc polyacrylamide gel electrophoresis. Overall, TRF was purified approximately 34,000-fold with a maximum 3.8% recovery of activity, and the specific activity of the purified TRF was approximately 9.6 X 10(4) U/mg. The TRF that is active in these systems is distinct from the other lymphokines such as IL 1, IL 2, BCGFI (now known as BSFp1), and gamma-interferon. The TRF is extremely hydrophobic, with an apparent m.w. of 50,000 to 60,000 on gel permeation chromatography and 18,000 on SDS-PAGE under reducing conditions. Highly purified B151-TRF abrogated the activity by treatment with trypsin but not with RNase. Moreover, it bound to lima bean agglutinin-Sepharose specific for N-acetylgalactosamine residues, indicating that B151-TRF is a glycosylated glycoprotein containing N-acetylgalactosamine residues. The role of N-acetylgalactosamine residues on TRF activity was additionally substantiated by the fact that the addition of appropriate amounts of N-acetylgalactosamine in the assay systems for TRF preferentially induced a profound suppression for TRF-mediated PFC responses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871109

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II.

Authors:  N Harada; T Takahashi; M Matsumoto; T Kinashi; J Ohara; Y Kikuchi; N Koyama; E Severinson; Y Yaoita; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines.

Authors:  S Mita; A Tominaga; Y Hitoshi; K Sakamoto; T Honjo; M Akagi; Y Kikuchi; N Yamaguchi; K Takatsu
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  T-cell-derived factor B151-TRF1/IL-5 activates blastoid cells among unprimed B cells to induce a polyclonal differentiation into immunoglobulin M-secreting cells.

Authors:  S Murakami; S Ono; N Harada; Y Hara; Y Katoh; K Dobashi; K Takatsu; T Hamaoka
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

4.  Three functionally distinct helper T-cell clones: the roles for antigen non-specific helper factors in B-cell activation through two different pathways.

Authors:  Y Sano; N Harada; K Takatsu
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

5.  T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells.

Authors:  M S Loughnan; K Takatsu; N Harada; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue.

Authors:  C Azuma; T Tanabe; M Konishi; T Kinashi; T Noma; F Matsuda; Y Yaoita; K Takatsu; L Hammarström; C I Smith
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

7.  Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli.

Authors:  A E Proudfoot; D Fattah; E H Kawashima; A Bernard; P T Wingfield
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

8.  Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

Authors:  T Hirano; T Taga; N Nakano; K Yasukawa; S Kashiwamura; K Shimizu; K Nakajima; K H Pyun; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation.

Authors:  N Koyama; N Harada; T Takahashi; S Mita; H Okamura; A Tominaga; K Takatsu
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

10.  Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes.

Authors:  K Takatsu; Y Kikuchi; T Takahashi; T Honjo; M Matsumoto; N Harada; N Yamaguchi; A Tominaga
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.